Showing results (51-60 of 190) with videos related to
Sort By:
Pageof 19
Molecular Therapy. Nucleic Acids|March 20, 2014
Targeted exon skipping to correct exon duplications in the dystrophin geneKane L Greer, Hanns Lochmüller, Kevin Flanigan, et al.International Journal of Molecular Sciences|October 21, 2020
Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in COL7A1Kristin A Ham, May Thandar Aung-Htut, Sue Fletcher, et al.The Journal of Gene Medicine|November 20, 2002
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophyChristopher J Mann, Kaite Honeyman, Graham McClorey, et al.International Journal of Molecular Sciences|November 6, 2019
Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA ProcessingCraig S McIntosh, May Thandar Aung-Htut, Sue Fletcher, et al.Biomedicines|November 27, 2021
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense TherapiesCraig S McIntosh, Dunhui Li, Steve D Wilton, et al.Journal of Biomolecular Screening|November 1, 2012
A cell-based high-throughput screening assay for posttranscriptional utrophin upregulationCatherine Moorwood, Neha Soni, Gopal Patel, et al.Neuromuscular Disorders : NMD|July 1, 1997
Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?S D Wilton, D E Dye, L M Blechynden, et al.FEBS Letters|December 21, 2018
YAPping about and not forgetting TAZBernard A Callus, Megan L Finch-Edmondson, Sue Fletcher, et al.Journal of Clinical Microbiology|January 1, 1992
Use of polymerase chain reaction for rapid diagnosis of tuberculosisD V Cousins, S D Wilton, B R Francis, et al.Journal of Cellular and Molecular Medicine|January 22, 2011
Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafishJoachim Berger, Silke Berger, Arie S Jacoby, et al.Pageof 19